Literature DB >> 6430269

Collagen composition of normal and myxomatous human mitral heart valves.

W G Cole, D Chan, A J Hickey, D E Wilcken.   

Abstract

The collagens were studied in 13 normal and 19 myxomatous human mitral valves. The collagens of the valve were completely solubilized by using a method consisting of guanidinium chloride extraction, limited pepsin digestions and CNBr cleavage of the residue. The normal valves contained 74% type I, 24% type III and 2% type V collagen. The type I and type III collagens had similar solubility patterns, although only type I collagen was detected in the guanidinium chloride extract. Type V collagen was only detected in the first pepsin extract. The type I and III collagens had higher contents of hydroxylysine than did the same collagens from age-matched dermis. The two-dimensional electrophoretic 'maps' of CNBr-cleavage peptides showed low recoveries of the C-terminal alpha 1(I) CB6 and alpha 1(III) CB9 peptides, which are involved in forming intermolecular cross-linkages. Most of the reducible cross-linkages were present in large-Mr peptide complexes, and these complexes were shown by labelling with 125I to include the tyrosine-containing alpha 1(I) CB6 peptide. The myxomatous valves contained 67% type I, 31% type III and 2% type V collagens. There was a significant increase in the concentration of each type of collagen, which consisted of a 9% increase of type I collagen, a 53% increase of type III collagen and a 25% increase of type V collagen. The contents of hydroxylysine in type I and III collagens and the electrophoretic 'maps' of the CNBr-cleavage peptides involved in cross-linkages did not differ significantly from the results obtained from the normal valves. The biochemical findings suggest that there is an increased production of collagen, in particular type III collagen, and glycosaminoglycan as well as a proliferation of cells as part of a repair process in the myxomatous valves.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430269      PMCID: PMC1153502          DOI: 10.1042/bj2190451

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis.

Authors:  P G Scott; A Veis
Journal:  Connect Tissue Res       Date:  1976       Impact factor: 3.417

2.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

Review 3.  Mitral valvular disease. A clinicopathologic survey of the conditions causing the mitral valve to function abnormally.

Authors:  W C Roberts; J K Perloff
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

4.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

5.  Isolation and characterization of a collagen from chick cartilage containing three identical alpha chains.

Authors:  E J Miller
Journal:  Biochemistry       Date:  1971-04-27       Impact factor: 3.162

6.  Reducible crosslinks in hydroxylysine-deficient collagens of a heritable disorder of connective tissue.

Authors:  D R Eyre; M J Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

7.  Defect in conversion of procollagen to collagen in a form of Ehlers-Danlos syndrome.

Authors:  J R Lichtenstein; G R Martin; L D Kohn; P H Byers; V A McKusick
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

8.  The iodination of chymotrypsinogen.

Authors:  A N Glazer; F Sanger
Journal:  Biochem J       Date:  1964-01       Impact factor: 3.857

9.  The estimation of two collagens from human dermis by interrupted gel electrophoresis.

Authors:  B Sykes; B Puddle; M Francis; R Smith
Journal:  Biochem Biophys Res Commun       Date:  1976-10-18       Impact factor: 3.575

10.  Prevalence of clinical mitral-valve prolapse in 1169 young women.

Authors:  P M Procacci; S V Savran; S L Schreiter; A L Bryson
Journal:  N Engl J Med       Date:  1976-05-13       Impact factor: 91.245

View more
  39 in total

1.  A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4.

Authors:  Lisa A Freed; James S Acierno; Daisy Dai; Maire Leyne; Jane E Marshall; Francesca Nesta; Robert A Levine; Susan A Slaugenhaupt
Journal:  Am J Hum Genet       Date:  2003-04-21       Impact factor: 11.025

2.  Perinatal changes in mitral and aortic valve structure and composition.

Authors:  Elizabeth H Stephens; Allison D Post; Daniel R Laucirica; K Jane Grande-Allen
Journal:  Pediatr Dev Pathol       Date:  2010-06-10

Review 3.  Heart Valve Biomechanics and Underlying Mechanobiology.

Authors:  Salma Ayoub; Giovanni Ferrari; Robert C Gorman; Joseph H Gorman; Frederick J Schoen; Michael S Sacks
Journal:  Compr Physiol       Date:  2016-09-15       Impact factor: 9.090

4.  Cardiac anomalies in Williams-Beuren syndrome.

Authors:  K A Hallidie-Smith; S Karas
Journal:  Arch Dis Child       Date:  1988-07       Impact factor: 3.791

5.  Peptide analysis of collagen produced from cDNA by transcription and translation in vitro.

Authors:  J F Bateman; S Lamande; D Chan; W G Cole
Journal:  Biochem J       Date:  1987-07-15       Impact factor: 3.857

6.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

7.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

8.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

9.  EmaA, a potential virulence determinant of Aggregatibacter actinomycetemcomitans in infective endocarditis.

Authors:  Gaoyan Tang; Todd Kitten; Cindy L Munro; George C Wellman; Keith P Mintz
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

Review 10.  Heart valve development: regulatory networks in development and disease.

Authors:  Michelle D Combs; Katherine E Yutzey
Journal:  Circ Res       Date:  2009-08-28       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.